Mark Miller

5.1k total citations · 1 hit paper
50 papers, 2.5k citations indexed

About

Mark Miller is a scholar working on Surgery, Infectious Diseases and Nutrition and Dietetics. According to data from OpenAlex, Mark Miller has authored 50 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Infectious Diseases and 7 papers in Nutrition and Dietetics. Recurrent topics in Mark Miller's work include Nitric Oxide and Endothelin Effects (5 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Gastrointestinal motility and disorders (3 papers). Mark Miller is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Gastrointestinal motility and disorders (3 papers). Mark Miller collaborates with scholars based in United States, Canada and United Kingdom. Mark Miller's co-authors include David A. Clark, H Sadowska-Krowicka, Somporn Chotinaruemol, Jane L. Kakkis, E. E. Mannick, Edward A. Panacek, Rodger D. MacArthur, William Barchuk, Leah Teoh and P Corréa and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Hypertension.

In The Last Decade

Mark Miller

49 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants.

1996 422 citations E. E. Mannick, Bernardo Ruiz et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Miller United States	22	566	469	443	411	364	50	2.5k
James P. Nolan United States	25	537 0.9×	417 0.9×	291 0.7×	395 1.0×	507 1.4×	59	2.4k
Selwyn A. Broitman United States	26	363 0.6×	584 1.2×	339 0.8×	582 1.4×	346 1.0×	84	2.7k
Klaus Bukhave Denmark	34	505 0.9×	1.0k 2.1×	440 1.0×	557 1.4×	271 0.7×	92	3.1k
K.A. Balasubramanian India	28	259 0.5×	371 0.8×	413 0.9×	728 1.8×	222 0.6×	109	2.6k
Riaz A. Memon United States	24	1.0k 1.8×	857 1.8×	558 1.3×	1.2k 2.8×	565 1.6×	53	3.6k
Alvin Denenberg United States	35	372 0.7×	333 0.7×	402 0.9×	1.1k 2.7×	767 2.1×	60	2.9k
Chi‐Chang Juan Taiwan	36	679 1.2×	421 0.9×	724 1.6×	1000 2.4×	168 0.5×	109	3.3k
José R. Romero United States	28	290 0.5×	413 0.9×	487 1.1×	816 2.0×	141 0.4×	116	2.6k
Steinar Skrede Norway	32	703 1.2×	705 1.5×	270 0.6×	848 2.1×	180 0.5×	156	3.1k
Adriana Ribeiro Silva Brazil	27	434 0.8×	250 0.5×	294 0.7×	1.2k 3.0×	571 1.6×	75	2.8k

Countries citing papers authored by Mark Miller

Since Specialization

Citations

This map shows the geographic impact of Mark Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Miller more than expected).

Fields of papers citing papers by Mark Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Miller. The network helps show where Mark Miller may publish in the future.

Co-authorship network of co-authors of Mark Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Miller. A scholar is included among the top collaborators of Mark Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Miller. Mark Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Mark, et al.. (2024). Examining Demographic Factors, Psychosocial Wellbeing and Cardiovascular Health in Subjective Cognitive Decline in the Brain Health Registry Cohort. The Journal of Prevention of Alzheimer s Disease. 11(3). 787–797. 6 indexed citations

McGuire, Dawn, N.E. Lane, Neil A. Segal, et al.. (2018). TPX-100 leads to marked, sustained improvements in subjects with knee osteoarthritis: pre-clinical rationale and results of a controlled clinical trial. Osteoarthritis and Cartilage. 26. S243–S243. 20 indexed citations

Akhtar, Nahid, Mark Miller, & Tariq M. Haqqi. (2011). Effect of a Herbal-Leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytes. BMC Complementary and Alternative Medicine. 11(1). 66–66. 42 indexed citations

Lévy, Corinne, Jennifer Brown, Wayne A. Ray, et al.. (2009). Hantavirus pulmonary syndrome in five pediatric patients - four states, 2009.. MMWR Morbidity and Mortality Weekly Report. 58(50). 1409–1412. 7 indexed citations

Miller, Mark, Brian K. Reuter, John L. Wallace, & Keith A. Sharkey. (2008). A unique therapeutic approach to emesis and itch with a proanthocyanidin-rich genonutrient. Journal of Translational Medicine. 6(1). 3–3. 5 indexed citations

Miller, Mark, Paul Bobrowski, Meenakshi Shukla, Kalpana Gupta, & Tariq M. Haqqi. (2007). Chondroprotective effects of a proanthocyanidin rich Amazonian genonutrient reflects direct inhibition of matrix metalloproteinases and upregulation of IGF-1 production by human chondrocytes. Journal of Inflammation. 4(1). 16–16. 16 indexed citations

Tagalakis, Vicky, Susan R. Kahn, José A. Correa, et al.. (2006). Thrombophilia in short peripheral catheter thrombophlebitis. Thrombosis Research. 119(5). 587–592. 3 indexed citations

Panacek, Edward A., John C. Marshall, Timothy E. Albertson, et al.. (2004). Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*. Critical Care Medicine. 32(11). 2173–2182. 267 indexed citations

Miller, Mark, Nathalie Vergnolle, Webb McKnight, et al.. (2001). Inhibition of Neurogenic Inflammation by the Amazonian Herbal Medicine Sangre de Grado. Journal of Investigative Dermatology. 117(3). 725–730. 27 indexed citations

10.

Singer, Joel, Anona Thorne, Peter Phillips, et al.. (1999). Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian Randomized MAC Treatment Trial. AIDS. 13(5). 575–582. 5 indexed citations

11.

Sadowska-Krowicka, H, E. E. Mannick, Peter Oliver, et al.. (1998). Genistein and Gut Inflammation: Role of Nitric Oxide. Experimental Biology and Medicine. 217(3). 351–357. 67 indexed citations

12.

Phillips, Peter, Stephen Shafran, Gary Garber, et al.. (1997). Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(5). 337–345. 172 indexed citations

13.

Zhang, Xiaojun, et al.. (1995). Omeprazole plus one or two antibiotics to eradicate H. pylori. Gastroenterology. 108(4). A63–A63. 5 indexed citations

14.

Martı́nez, Alfredo, Mark Miller, Katie Quinn, et al.. (1995). Non-radioactive localization of nucleic acids by direct in situ PCR and in situ RT-PCR in paraffin-embedded sections.. Journal of Histochemistry & Cytochemistry. 43(8). 739–747. 65 indexed citations

15.

Bustamante, Sergio A., et al.. (1994). Dietary Nucleotides: Effects on the Gastrointestinal System in Swine. Journal of Nutrition. 124(13). 149S–156S. 23 indexed citations

16.

Miller, Mark, et al.. (1993). Anti‐inflammatory agents and substance P depletion in experimental ileitis. Mediators of Inflammation. 2(4). 293–297. 3 indexed citations

17.

Balwierczak, Joseph L., et al.. (1991). Comparative effects of a selective adenosine A2 receptor agonist, CGS 21680, and nitroprusside in vascular smooth muscle. European Journal of Pharmacology. 196(2). 117–123. 35 indexed citations

18.

Miller, Mark & Jack H. Mendelson. (1990). Rapid Diagnosis of Bacteremia in Adults Using Acridine Orange Stained Buffy Coat Smears. Canadian Journal of Infectious Diseases and Medical Microbiology. 1(1). 7–10. 1 indexed citations

19.

Miller, Mark, et al.. (1990). Casein: A Milk Protein with Diverse Biologic Consequences. Experimental Biology and Medicine. 195(2). 143–159. 46 indexed citations

20.

Lefor, Alan Kawarai & Mark Miller. (1985). Factitious hypoglycemia associated with eosinophilic leukemoid reaction.. PubMed. 85(1). 34–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact